Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Acquisitions
The acquisitions for Labcorp Holdings Inc. (LH) is $582.00 Million with a year-over-year change of -29.36%. Acquisitions represent cash spent to acquire other businesses and show externally purchased growth activity.
LH Acquisitions Chart
LH Acquisitions
$582.00M+69.88% 20Y
Zoom
Current Acquisitions
$582.00M
$582.00 Million
Year-over-Year Change
-29.36%
vs. $823.90M prior year
Historical Data
30
Years of data available
Annual Acquisitions History
| Year | Acquisitions | YoY Change | % Change |
|---|---|---|---|
| 2025 | $582.00M | $-241.90M | -29.36% |
| 2024 | $823.90M | +$152.40M | +22.70% |
| 2023 | $671.50M | $-490.90M | -42.23% |
| 2022 | $1.16B | +$665.50M | +133.93% |
| 2021 | $496.90M | +$229.30M | +85.69% |
| 2020 | $267.60M | $-608.40M | -69.45% |
| 2019 | $876.00M | +$739.60M | +542.23% |
| 2018 | $136.40M | $-1.78B | -92.89% |
| 2017 | $1.92B | +$1.36B | +241.97% |
| 2016 | $561.10M | $-3.19B | -85.03% |
| 2015 | $3.75B | +$3.57B | +1986.69% |
| 2014 | $179.60M | +$13.60M | +8.19% |
| 2013 | $166.00M | $-195.10M | -54.03% |
| 2012 | $361.10M | +$222.80M | +161.10% |
| 2011 | $138.30M | $-1.05B | -88.34% |
| 2010 | $1.19B | +$969.90M | +449.24% |
| 2009 | $215.90M | $-133.00M | -38.12% |
| 2008 | $348.90M | +$123.80M | +55.00% |
| 2007 | $225.10M | +$185.10M | +462.75% |
| 2006 | $40.00M | $-302.60M | -88.32% |
| 2005 | $342.60M | +$302.60M | +756.50% |
| 2004 | $40.00M | $-607.50M | -93.82% |
| 2003 | $647.50M | +$385.60M | +147.23% |
| 2002 | $261.90M | +$120.80M | +85.61% |
| 2001 | $141.10M | +$46.20M | +48.68% |
| 2000 | $94.90M | +$94.90M | — |
| 1999 | $0 | +$0 | — |
| 1998 | $0 | +$0 | — |
| 1997 | $0 | +$0 | — |
| 1996 | $0 | — | — |
Related Metrics
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter